Home › Funds › Vanguard Group › ADPT

Vanguard Group position in ADPT

ADAPTIVE BIOTECHNOLOGIES COR · Health Care

Latest position (Q4 2025)11.28M sh
Reported value held$183.22M
Portfolio Weight0.00%
First reportedQ1 2021
Last changeHold

Quarter by quarter

QuarterSharesValueChange
Q1 2021 10.02M $403.49M New
Q2 2021 10.18M $415.86M Add
Q3 2021 10.99M $373.57M Add
Q4 2021 11.03M $309.54M Hold
Q1 2022 11.09M $153.94M Add
Q2 2022 11.58M $93.65M Add
Q3 2022 11.67M $83.10M Add
Q4 2022 11.79M $90.11M Add
Q1 2023 11.98M $105.76M Add
Q2 2023 12.05M $80.87M Add
Q3 2023 12.25M $66.76M Add
Q4 2023 12.77M $62.56M Add
Q1 2024 12.87M $41.31M Add
Q2 2024 10.23M $37.02M Reduce
Q3 2024 10.64M $54.47M Add
Q4 2024 10.71M $64.24M Add
Q1 2025 11.14M $82.80M Add
Q2 2025 11.28M $131.40M Add
Q3 2025 11.28M $168.68M Hold
Q4 2025 11.28M $183.22M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding ADPT

All ADPT fund holders →